Cleared Traditional

K142505 - ClearPoint System

K142505 is an FDA 510(k) clearance for ClearPoint System, manufactured by Mri Interventions, Inc.. The device is a Class 2 Neurology device with product code HAW cleared through the Traditional 510(k) pathway after a 411-day FDA review.

K142505 · Mri Interventions, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2015
Decision
411d
Days
Class 2
Risk

K142505 is an FDA 510(k) clearance for the ClearPoint System. Classified as Neurological Stereotaxic Instrument (product code HAW), Class II - Special Controls.

Submitted by Mri Interventions, Inc. (Irvine, US). The FDA issued a Cleared decision on October 21, 2015 after a review of 411 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4560 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Neurology submissions.

View all Mri Interventions, Inc. devices

FDA 510(k) Submission Details - K142505

510(k) Number K142505 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 05, 2014
Decision Date October 21, 2015
Days to Decision 411 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
263d slower than avg
Panel avg: 148d · This submission: 411d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HAW Device Classification - Class 2, Special Controls

Product Code HAW Neurological Stereotaxic Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.4560
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HAW Neurological Stereotaxic Instrument

All 331
Devices cleared under the same product code (HAW) and FDA review panel - the closest regulatory comparables to K142505.
Leksell Stereotactic System, Injection/ Aspiration Needle Kit
K152558 · Elekta Instrument AB · Mar 2016
ROSA Brain
K151359 · Medtech S.A · Dec 2015
SYMBIS Surgical System
K143420 · Imris, Inc. · Oct 2015
NavSuite3 Kit
K150301 · Stryker Leibinger GmbH & Co. KG - Navigation · Jul 2015
Synergy Cranial
K150216 · Medtronic Navigation, Inc. · Jun 2015
MDT Navigable Brain Biopsy Cannula
K143241 · Izi Medical Products, LLC · Apr 2015